Stock Taper 
GF FUND MANAGEMENT CO. LTD.
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 NETSTREIT Corp. | NTST | 1.31K | $27.64K |
 Jazz Pharmaceuticals plc | JAZZ | 1.3K | $314.47K |
 Ascendis Pharma A/S | ASND | 1.3K | $348.07K |
 Abivax S.A. | ABVX | 1.3K | $173.5K |
 Twist Bioscience Corporation | TWST | 1.3K | $133.74K |
 Kodiak Sciences Inc. | KOD | 1.29K | $50.41K |
 Janux Therapeutics, Inc. | JANX | 1.29K | $19.8K |
 Camden Property Trust | CPT | 1.29K | $147.35K |
 Mirum Pharmaceuticals, Inc. | MIRM | 1.28K | $149.85K |
 Xenia Hotels & Resorts, Inc. | XHR | 1.27K | $25.82K |
 Enliven Therapeutics, Inc. | ELVN | 1.26K | $63.84K |
 Cullinan Therapeutics, Inc. | CGEM | 1.25K | $22.8K |
 Curbline Properties Corp. | CURB | 1.24K | $37.82K |
 Agios Pharmaceuticals, Inc. | AGIO | 1.24K | $46.09K |
 Vanda Pharmaceuticals Inc. | VNDA | 1.23K | $7.55K |
 Harmony Biosciences Holdings, Inc. | HRMY | 1.23K | $44.67K |
 Supernus Pharmaceuticals, Inc. | SUPN | 1.22K | $56.56K |
 Stoke Therapeutics, Inc. | STOK | 1.21K | $39.66K |
 Design Therapeutics, Inc. | DSGN | 1.21K | $17.49K |
 Zevra Therapeutics, Inc. | ZVRA | 1.19K | $17.12K |